https://www.selleckchem.com/pr....oducts/selonsertib-g
71, 95% CI 1.24 to 2.35). Moreover, patients with ACP were less likely to receive cardiopulmonary resuscitation (AOR 0.36, 95% CI 0.25 to 0.51) as well as intubation and mechanical ventilation support (AOR 0.54, 95% CI 0.44 to 0.67) during the last 3 months of life. Patients with ACP were more likely to die at home and less likely to receive life-sustaining treatments during EOL care. Patients with ACP were more likely to die at home and less likely to receive life-sustaining treatments during EOL care.We aim to understand,
Curtir
Comentario
Compartilhar
